Duopharma Biotech Berhad (KLSE: DPHARMA)

Duopharma Biotech Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	260.42	270.5	157.64	137.98	158.03	120.67
Cash & Short-Term Investments	260.42	270.5	157.64	137.98	158.03	120.67
Cash Growth	-7.61%	71.60%	14.25%	-12.69%	30.96%	22.81%
Accounts Receivable	223.67	135.04	131.31	122.42	112.99	111.89
Other Receivables	21.23	26.38	10.84	10.31	22.18	18.9
Receivables	244.91	161.42	142.15	132.72	135.17	130.79
Inventory	219.97	243.07	235.18	222.19	151.27	144
Prepaid Expenses	-	2.08	6.52	1.9	0.67	0.77
Other Current Assets	-	-	-	-	14.56	20.97
Total Current Assets	725.29	677.07	541.49	494.8	459.69	417.21
Property, Plant & Equipment	557.85	582.37	579.92	542.53	441.79	412.25
Long-Term Investments	24.23	36.91	42.15	73.54	112.25	51.84
Other Intangible Assets	37	7.65	3.84	4.95	4.66	0.6
Long-Term Deferred Tax Assets	7.52	8.95	13.33	12.7	8.54	9.2
Long-Term Deferred Charges	-	31.15	40.14	34.58	30.41	27.52
Other Long-Term Assets	1.05	1.05	1.05	1.05	1.1	1.2
Total Assets	1,353	1,345	1,222	1,164	1,058	919.8
Accounts Payable	109.82	44.53	51.93	31.32	28.15	34.67
Accrued Expenses	-	33.79	40.46	61.2	45.62	56.6
Short-Term Debt	-	50.59	101.8	87.85	36.11	109.66
Current Portion of Long-Term Debt	55.82	14.95	32.34	15.08	12.68	15
Current Portion of Leases	-	0.92	0.94	0.64	0.6	0.78
Current Income Taxes Payable	1.92	0.37	1.17	6.06	0.74	0.65
Other Current Liabilities	-	21.58	35.95	28.17	26.41	22.08
Total Current Liabilities	167.56	166.73	264.59	230.31	150.32	239.44
Long-Term Debt	468.68	480.9	294.6	297.8	253.28	139.74
Long-Term Leases	2.92	1.48	1.92	2.48	0.66	0.82
Long-Term Deferred Tax Liabilities	17.73	8.91	5.58	9.54	10.35	10.05
Total Liabilities	656.88	658.01	566.7	540.13	414.61	390.05
Common Stock	432.47	432.47	419.37	405.86	404.92	374.4
Retained Earnings	339.69	319.07	288.37	239.97	220.18	182.95
Comprehensive Income & Other	-76.11	-64.41	-52.52	-21.82	18.72	-27.6
Shareholders' Equity	696.05	687.12	655.22	624	643.82	529.75
Total Liabilities & Equity	1,353	1,345	1,222	1,164	1,058	919.8
Total Debt	527.41	548.85	431.6	403.84	303.33	266
Net Cash (Debt)	-266.99	-278.35	-273.97	-265.86	-145.31	-145.33
Net Cash Per Share	-0.28	-0.29	-0.29	-0.29	-0.16	-0.16
Filing Date Shares Outstanding	961.94	961.94	952.24	941.77	941.37	912.51
Total Common Shares Outstanding	961.94	961.94	952.24	941.77	941.37	912.51
Working Capital	557.73	510.34	276.9	264.49	309.37	177.76
Book Value Per Share	0.72	0.71	0.69	0.66	0.68	0.58
Tangible Book Value	659.05	679.47	651.38	619.06	639.16	529.16
Tangible Book Value Per Share	0.69	0.71	0.68	0.66	0.68	0.58
Land	-	65.68	69.88	69.88	69.88	69.88
Buildings	-	265.86	125.23	124.51	119.57	58.67
Machinery	-	435.18	368.47	308.94	291.64	269.57
Construction In Progress	-	8.48	172.65	162.63	65.81	93.33

Source: S&P Capital IQ. Standard template. Financial Sources.